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Abstract
The Escherichia coli oligoribonuclease, ORN, has a 39 to 59 exonuclease activity specific for small oligomers that is essential
for cell viability. The human homologue, REXO2, has hitherto been incompletely characterized, with only its in vitro ability to
degrade small single-stranded RNA and DNA fragments documented. Here we show that the human enzyme has clear dual
cellular localization being present both in cytosolic and mitochondrial fractions. Interestingly, the mitochondrial form
localizes to both the intermembrane space and the matrix. Depletion of REXO2 by RNA interference causes a strong
morphological phenotype in human cells, which show a disorganized network of punctate and granular mitochondria. Lack
of REXO2 protein also causes a substantial decrease of mitochondrial nucleic acid content and impaired de novo
mitochondrial protein synthesis. Our data constitute the first in vivo evidence for an oligoribonuclease activity in human
mitochondria.
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Introduction
Ribonucleases are enzymes capable of cleaving the phospho-
diester bonds between the nucleotide subunits of RNA molecules.
Both endo- and exoribonucleases play important roles in the
regulation of RNA levels, performing functions in both RNA
processing and degradation [1]. All the known exoribonucleases
have been divided into six superfamilies based on their sequence,
structure and catalytic activity, with the vast majority exhibiting 39
to 59 degrading activity [2]. The largest is the superfamily DnaQ-
like or DEDD named for the four conserved acidic residues that
cluster around the catalytic site of all family members. This
distinctive core is essential for binding the divalent metal ions that
are required for catalysis [3]. The DnaQ-like domain contains
three conserved sequence motifs, namely ExoI, ExoII and ExoIII
[4,5], each containing this distinctive core although the conserva-
tion patterns of the three motifs may vary between different
subfamilies.
One group of the DEDD superfamily contains oligoribonu-
cleases (oligoRNases) that are essentially specific for small single-
stranded RNA fragments of less than five nucleotides in length,
although some including human also display DNase activity. An
intriguing feature of this group is their high conservation and
distribution among the different phyla: they are represented in
vertebrates, invertebrates (insects and worms), yeast and some
plants [6]. Functional studies of the orn gene in E. coli have
suggested that inactivation gives rise to the deleterious accumu-
lation of short oligoribonucleotides causing cell death, confirming
that the enzyme performs a critical role in cell metabolism [7].
Depletion of ORN in P. aeruginosa also promotes accumulation of
short RNA species, which are able to prime transcription, such
that depletion results in global alterations in gene expression [8].
These examples demonstrate that oligoribonucleases perform
crucial functions in the final steps of RNA decay and can
influence the transcription initiation process in bacteria.
The ORN homologue in S. cerevisiae, named YNT20 [9] or
REX2p, has been shown to localize to mitochondria and to have a
function in the mitochondrial DNA escape pathway that is
mediated by YME1, a protease tightly associated with the inner
mitochondrial membrane [10]. In contrast to its previous
characterization as exclusively mitochondrial, YNT20 is required
for the processing of U4, U5L, U5S snRNAs as well as for the
maturation of RNA components of both RNase P and 5.8S rRNA
in yeast [11] all processes that occur within the nucleus.
Very few human mitochondrial RNases have been fully
characterized and none appear to be responsible for degrading
very short oligoribonucleotides into monoribonucleotides as the
final step of mitochondrial RNA decay process [12]. Here we
demonstrate that REXO2 is indeed an active mitochondrial
protein, which is also localised to the cytosol. We provide evidence
that this enzyme is essential for cell turnover and whose depletion
affects mitochondrial structure and function. Surprisingly, we
found the majority of REXO2 to be localized in the intermem-
brane space (IMS) and comment on this observation in our
discussion.
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Materials and Methods
Tissue Culture, and Transfections
Human HeLa cells were cultured (37uC, humidified 5% CO2)
in Eagle’s MEM (Sigma) supplemented with 10% (v/v) foetal calf
serum (FCS), 16non-essential amino acids (NEAA) and 2 mM L-
glutamine. 143B.206 rho0 osteosarcoma cells [13] were propagat-
ed in Dulbecco’s modified Eagle’s medium supplemented with
10% (v/v) FCS, 50 mg/ml uridine and 16NEAA. Flp-InT-Rex-
293 cells (HEK293T; Invitrogen) were grown in identical media
supplemented with 10 mg/ml BlasticidinS and 100 mg/ml Zeocin
(Invitrogen) and transfected as previously described [14]. Post
transfection selection was performed with HygromycinB (100 mg/
ml).
Stable transfections were performed using constructs described
below and Superfect (Qiagen) using manufacturer’s recommen-
dations.
SiRNA transfections were performed with 60% confluent HeLa
cells using Lipofectamine RNAiMAX (Invitrogen) in Optimem-I
medium (Gibco) with 25 nM siRNA. Reverse transfections were
performed as described by Ovcharenko et al (2005) [15] using
approximately 12 000 HEK293 Tcell per cm2 using Lipofecta-
mine RNAiMAX in Optimem-I medium (25 nM siRNA). Custom
and control non-targetting (NT, Eurogentec ref OR-0030-neg05)
duplex siRNAs were purchased pre-annealed from Eurogentec
(REXO2 sense 59-GCAGGCAGAGUAUGAAUUUdTdT; anti-
sense 59- AAAUUCAUACUCUGCCUGCdTdT.).
All constructs were prepared by PCR using an oligo-dT primed
cDNA pool as template. Constructs to facilitate inducible
expression of full length C-terminal FLAG-tagged REXO2 were
prepared by generating an amplicon from nt 134 to 851
(NM_015523.3) using the following primer pair: FL For 59-
CACACAGGATCCGTCCCGGGTGATGCTAG -39 and FL
FLAG Rev 59- ACTCGACTCGAGCTACTTATCGTCGT-
CATCCTTGTAATCCACGGTCTTCTCATTTTCC -39. The
mature, N-terminal truncated untagged REXO2 was amplified
using forward primer 59- CACACAGGATCCAC-
CATGGTCCGCGAAGGTGGC paired with REXO2 no tag
rev 59- ACTCGACTCGAGTCAACTCACGGTCTTCTC. Full
length untagged REXO2 was amplified using FL For and REXO2
no tag rev primers. The amplicons and pcDNA5/FRT/TO
(Invitrogen) were digested with BamHI/XhoI (sites underlined)
and ligated. The GST-fusion construct was made of the mature
form of REXO2. The PCR product was generated using the
primer pair 59- CACACAGGATCCGTCCGCGAAGGTGGC
and REXO2 rev primer above incorporating a BamHI site in the
forward and XhoI site in the reverse primers. The amplicon and
vector were digested to allow in-frame fusion of REXO2-GST in
pGEX-6P-1 (GE Healthcare).
The constructs derived from pGEX-6P-1 or pcDNA5/FRT/
TO were used for transfection of E. coli Rosetta pLysS (Merck
Biosciences) or HEK293 T cells, respectively. Bacteria were
induced, then protein was purified and cleaved from GST using
PreScission Protease exactly as previously described for mtRRF
[16].
Mitochondrial Preparation and Subfractionation
For subcellular localization cells were harvested, resuspended in
homogenization buffer (HB, 0.6 M Mannitol, 1 mM EGTA,
10 mM Tris-HCl pH 7.4) +0.1% BSA, subjected to standard
differential centrifugation with mitochondria being finally pelleted
at 11 kg, 10 mins, 4uC and resuspended in HB. The postmi-
tochondrial fraction was retained after centrifugation of the first
homogenization. Aliquots of mitochondria were treated with
proteinase K (4 mg/100 mg protein) for 30 min at 4uC and either
lysed (1% final v/v Triton X-100) or treated with 1 mM PMSF
before separation through 15% PAG and transfer to a PVDF
membrane. For sub-mitochondrial fractionation, 300mg of mito-
chondria prepared as described above were then treated with
proteinase K (1.5mg) on ice for 30 mins followed by addition of
PMSF (5 mM) to generate shaved mitochondria. This was pelleted
at 11 kg, 10 mins, 4uC and resuspended in HB (75ml), with 15ml
removed as shaved mitochondria. The remainder was pelleted and
resuspended in 9 volumes of 10 mM Tris-HCl pH 7.4, divided in
half and proteinase K (0.6mg) added to one sample. Both samples
were left on ice for 30 mins before addition of PMSF (5 mM) and
an equal volume of 1.2 M Mannitol, 2 mM EGTA, 10 mM Tris-
HCl pH 7.4. After centrifugation at 12 kg, 10 mins, 4uC, both
pellets were resuspended in HB (30ml), and 15ml of each were
retained as shaved and unshaved mitoplasts. To prepare the inner
membrane fraction, HB (435ml) was added to the proteinase K
treated mitoplasts, which were pelleted at 12 kg, pellet was
dissolved in 100 mM Na2CO3 and incubated for 10 mins at 4uC.
This was centrifuged at 100 kg for 15 mins at 4uC after which the
pellet was resuspended in 26dissociation buffer (20% (v/v)
glycerol, 4% (w/v) SDS, 250 mM Tris-HCl pH 6.8, 100 mM
DTT).
Imaging
For nucleoid and mitochondria morphology imaging, cells were
incubated with 3ml/ml PicoGreen (Quant-ITTM, Invitrogen) in
culture media, for 1 h at 37uC with 5% CO2. 5 nM tetra-
methylrhodamine methyl ester (TMRM+, Invitrogen) was added
in the last 15 min of incubation and kept throughout washing and
imaging in assay buffer containing 135 mM NaCl, 5 mM KCl,
0.4 mM KH2PO4, 1.3 mM CaCl2, 1 mM MgSO4, 5.5 mM
glucose and 20 mM HEPES (pH 7.4 with NaOH). Imaging
acquisition was performed at 636magnification with an inverted
fluorescence microscope (Axiovert 200 M, Carl Zeiss) equipped
with FITC and Texas Red filters.
For in situ respiratory chain analysis, cells were incubated and
assayed in the presence of 25 nM TMRM+. Inhibition of
respiratory complexes was performed by the following order: 1)
Complex V (2mg/ml oligomycin); 2) Complex I (1mM rotenone);
and Complex III (2.5mM antimycin A). Full collapse of
mitochondrial membrane potential was evoked at the end of
experiments by adding uncoupler (1mM FCCP). Fluorescence
time-lapse imaging was performed at 30 s intervals to minimize
photobleaching, using 106 magnification and the Texas Red
filter. 25 nM TMRM+ sufficed for ‘quench mode’ imaging in our
experimental conditions, allowing the ‘oligomycin null-test’ for
forward vs. reverse ATPase operation (increased vs. decreased
quenching), and the assessment of depolarization by dequenching
upon complex I or III inhibition [17].
Cell Cycle Analysis
Cell cycle analyses were made on a 3 laser (633 nm, 488 nm
and 405 nm) FACSCanto II (Becton Dickinson) with measure-
ments for propidium iodide excitation from the 488 laser and
collected using a 585/42 bandpass PMT filter and analysed with
FACSDiva 6.1.3 software.
Northern Blotting
Northern blots were performed as described in [18]. Briefly,
aliquots of RNA (5 mg) were electrophoresed through 1.2%
agarose under denaturing conditions and transferred to Gene-
screenPlus membrane (NEN duPont) following the manufacturer’s
protocol. Radiolabelled probes were generated using random
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hexamers on PCR-generated templates corresponding to internal
regions of the relevant genes.
High resolution northerns were used to analyse tRNAs. Total
RNA (2mg) was denatured in 40% formamide/5 mM EDTA at
65uC, 5 mins before being separated through 15% urea
polyacrylamide gels in 16 TBE (89 mM Tris borate, 89 mM
boric acid, 2 mM EDTA). RNA was transferred to Genescreen-
Plus membrane (NEN DuPont) in 0.256 TBE at 150 mA,
15 mins followed by 500 mA for 30 mins after which the
membrane was exposed to UV (optimal crosslink, Stratalinker,
Stratagene) Hybridisation and probes were as described [19].
qPCR and Southern Blotting
PCR was used to generate 7S probe using the following primer
pairs:- For 59- CTCAACTATCACACATCAACTG and Rev 59-
AGATACTGCGACATAGGGTG, spanning residues 129 to
16223 of the D-loop [20,21] and 18S For 59- AAACGGCTAC-
CACATCCAAG and Rev 59-GGCCTCACTAAACCATCCAA.
To detect levels and/or depletion of mtDNA the following
primer pairs were used that were internal to the gene: ND1 For 59-
AATCGCAATGGCATTCC with ND1 Rev 59-CGATGGTGA-
GAGCTAAGG; ND4 For 59-CCATTCTCCTCCTATCCCT-
CAAC with ND4 Rev 59-CACAATCTGATGTTTTGGT-
TAAACTATATTT; 18S For 59-
GTAACCCGTTGAACCCCATT and 18S Rev 59- CCATC-
CAATCGGTAGTAGCG.
Immunoblotting
Western blots were performed and developed as described in
[14] and BlueNative PAGE as in [22] using antibodies as follows :
COXI, COX2, NDUFA9, NDUFB8, CV-subunit b, porin
(Mitosciences); b-actin, FLAG (Sigma); AIF, S6 (NEB); TOM20
(Santa Cruz); REXO2, GDH custom made and against mature
recombinant protein.
OligoRNase Activity Assays
Oligoribonuclease assays were performed essentially as
described by Nguyen LH et al [23] with minor modifications.
100 fmol of single-stranded 5-mer RNA (59-GAUCG-39,
labelled at 59 end with Alexa 647H1005 fluorophore; Euro-
gentec) was incubated with either 50–500 fmol of purified
recombinant REXO2 or 0.2–5 mg of total cell or mitochondrial
lysates. Incubation was carried out at 37uC, unless otherwise
indicated, for 30 mins in nuclease buffer [50 mM HEPES-KOH
pH 7.4, 50 mM potassium chloride, 10 mM manganese chlo-
ride, 0.01% Triton X-100, 10% glycerol and 0.1 mM DTT].
Reactions were terminated with an equal volume of 100%
formamide, heated at 80uC for 3 mins and loaded on a 25%
polyacrylamide gel without urea. Immediately after the run,
fluorescent products were detected using the STORM 860
PhosphorImager (GE Healthcare Life Sciences) and densitomet-
ric analysis was made with Image Quant software (GE
Healthcare Life Sciences).
De Novo Mitochondrial Protein Synthesis
Mitochondrial protein synthesis in cultured cells was performed
as described by Chomyn (1996) [24] after addition of emetine and
pulsed with [35S] methionine/cysteine for 2 hours with a 1 hour
chase. Aliquots (50 mg) of total cell protein were separated by 15–
20% (w/v) gradient SDS–PAGE. Signals were detected using the
Storm 860 PhosphorImager and ImageQuant software.
Results
Dual Localization of REXO2 to the Cytosol and
Mitochondria
Empirical scanning of the Mitocarta database [25] to identify
mitochondrial proteins with predicted ribonuclease activity
revealed few candidates. We identified one protein, REXO2
(UniProtKB accession: Q9Y3B8; ref seq NP_056338.2), which
appears to be ubiquitously expressed in all tissues and organisms.
Various algorithms (MitoProt II, TargetP, PSort and Predotar)
gave a very high probability of mitochondrial localization, with a
predicted pre-sequence of 25 amino acid (TargetP and PSort).
To experimentally determine the subcellular localization of
REXO2, we established a stable human HEK293T cell line
inducibly expressing the full length open reading frame carrying a
C-terminal FLAG peptide. Following induction cells were
fractionated and analysed by western blotting using an anti-FLAG
antibody. REXO2 was found localized both to the cytosol and
mitochondria (Figure 1A). The post-mitochondrial supernatant
contained a second product of lower mobility (indicated by arrow)
that was presumed to be the unprocessed mitochondrial precursor.
Crucially, this dual localization was also observed for endogenous
REXO2 in HeLa cells using custom made anti-REXO2 antibody
(Figure 1B). Proteinase K treatment of mitochondria (Figure 1B,
lane 3) confirmed that REXO2 is within mitochondria and not
simply associated with the outer membrane. Intriguingly, both the
endogenous cytosolic (lane 1) and mitochondrial (lanes 3 and 4)
forms had similar mobility of approx. 24 kDa, smaller than the
predicted Mr of the product encoded by the entire open reading
frame (26.8 kDa). Indeed, 24 kDa was similar to the expected size
of the mature mitochondrial form after predicted cleavage of
25 N-terminal amino acids (24.4 kDa). The alignment of multiple
genomic sequences from several eutherian mammals in the region
of the NCBI predicted start site, (Figure S1) shows two in-frame
AUGs that are positioned within this region of high conservation.
The 59 proximal AUG has a weak context for translation
initiation, potentially encoding the mitochondrial preprotein,
while the distal AUG possesses an optimal Kozak consensus
facilitating expression of a similar protein without the presequence
(23.8 kDa) [26]. An inducible construct lacking the 59 region of the
open reading frame and retaining only the downstream AUG
initiation site expressed a product of comparable mobility (Fig 1D
lanes 3, 4 cf. lane 1) after siRNA depletion of the endogenous
protein. This data is consistent with the expression of two isoforms
being differentially localized dependent on alternative translation
initiation at two in-frame AUGs. We cannot preclude the
possibility that only the downstream AUG is used naturally,
although this would require mitochondrial localisation and import
of only a subset of the polypeptide. Further, the translation
initiation complex would need to ignore the 59 proximal AUG
completely. It is also possible that if cleaved, the mature protein
could be further trimmed at the N-terminal. Irrespective, the data
clearly shows dual cellular localisation of REXO2.
Sub-mitochondrial Localization of REXO2
The intra-mitochondrial localization of REXO2 was then
examined by immunoblot of subfractionated HeLa cell organelles
(Figure 2A). When intact mitochondria were treated with
proteinase K, REXO2 remained intact whereas TOM20, a
marker of the outer mitochondrial membrane (OMM), was lost
(Figure 2A, lanes 1 and 2). Following OMM disruption, by
hypotonic shock to release soluble intermembrane space (IMS)
proteins, REXO2 levels dropped dramatically (Figure 2A, lane 3)
as did those of the IMS marker apoptosis-inducing factor (AIF). In
REXO2 Is a Human Mitochondrial Oligoribonuclease
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contrast, glutamate dehydrogenase (GDH), a mitochondrial
matrix marker, remained. Proteinase K treatment of these
mitoplasts did not further reduce REXO2 signal whilst AIF was
no longer detectable (Figure 2A, lane 4) consistent with a fraction
of REXO2 being present in the matrix. Inner mitochondrial
membrane (IMM) proteins were prepared by sodium carbonate
treatment of mitoplasts. In this fraction (Figure 2A, lane 5),
REXO2 was undetectable unlike an IMM marker NDUFA9, a
member of Complex I. These data infer the majority, but not all,
of the mitochondrial REXO2 is present in the IMS.
Mitochondrial REXO2 is an Active oligoRNase
The ribonuclease activity of REXO2 was tested with various
nucleic acid templates but showed a clear preference for
oligoRNAs was observed. All subsequent experiments used a
single-stranded 5-mer RNA, 59 labelled with ALEXA 647, as
substrate (RNA5). Initial assays used a recombinant version of the
mature REXO2 Purified, soluble REXO2 was incubated with
substrate at 37uC and 50uC. Robust activity was observed at 37uC
with activity retained at 50uC (Figure S2). Mitochondrial and total
protein extracts were tested using identical experimental condi-
tions. OligoRNase activity was clearly present in the mitochondrial
fraction (Figure 2B). Total cell extract produced greater substrate
degradation as expected since both the mitochondrial and
cytosolic enzymes will contribute (Figure 2B). Bacterial ORN
retains activity at temperatures that typically inactivate the
majority of RNases [27]. We therefore tested the mitochondrial
fraction for similar heat resistance. Reminiscent of the bacterial
enzyme, oligoRNase activity was still detectable at 65uC but
retained only minimal activity at 80uC (data not shown).
Is REXO2 responsible for this oligoRNase activity in human
mitochondria? To address this, we tested mitochondrial extracts
from HEK293T cells overexpressing REXO2 and uninduced
controls. Consistent with the hypothesis, the former showed higher
levels of robust oligoRNase activity (Figure 2C).
We subsequently tested all the submitochondrial fractions for
RNase activity. The activity (Figure 2D) paralleled the distribution
of REXO2 observed by western blotting (Figure 2A), in particular
showing a greater activity in the whole organelle compared to the
mitoplast (Figure 2D, Lane 3 cf lane 5) consistent with greater
levels of the enzyme in the IMS than matrix. However, proteinase
K treated mitoplasts did retain significant oligoRNase activity
confirming that REXO2 is also active in the mitochondrial matrix.
To extend the correlative evidence, mitochondria extracted from
REXO2 depleted samples were tested for oligoRNase activity and
a decrease in activity was confirmed (Figure 2E).
Figure 1. REXO2 is dual localised both to mitochondria and the cytosol. HEK293 cells were engineered to express FLAG tagged REXO2
(panel A lanes 2 and 4). Western blots of post mitochondrial supernatant (40 mg, lanes 1 and 2) and mitochondria (40 mg) were probed with
antibodies against a mitochondrial complex I protein (NDUFA9) and FLAG peptide. Arrow indicates species of slower mobility described in text. Panel
B is a representative western blot of untransfected HeLa cells (30 mg) probed with antibodies to REXO2, a marker of the cytosol (S6 ribosomal protein)
and mitochondrial (NDUFA9). C. Schematic representation of the cDNA encoding REXO2. The two putative translation initiation sites, at amino acid 1
for the full length (FL) and 33 for the cytosolic (C), as well as the predicted cleavage site to generate the mitochondrial mature form following import,
are indicated. The position of the siRNA target is indicated, where silent mutations in the cDNA were engineered to render the siRNA unable to bind
exogenously expressed transcript. D. HEK293 cell lysates (50 mg) from controls treated with non-targetting (NT) siRNA (lanes 1 and 5), cells depleted
of REXO2 (RX) (lanes 2, 3 and 6, 7) or expressing the cDNA encoding the cytosolic form only (C; lanes 3 and 4) or full length (FL; lanes 7 and 8) form of
REXO2 were analysed by western blot and probed with antibodies to endogenous REXO2. Antibodies to the mitochondrial outer membrane protein
porin, or cytosolic b-actin were used as loading controls.
doi:10.1371/journal.pone.0064670.g001
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Figure 2. REXO2 localises to two mitochondrial subcompartments where it is active as an oligoRNase. A. Mitochondria were prepared
from HeLa cells (lane 1), treated with proteinase K (PK) (lane 2) and further subfractionated to give mitoplasts (lane 3), PK shaved mitoplasts (lane 4)
and inner membrane fractions (sodium carbonate, lane 5). Aliquots (10 mg) were then subjected to western blotting with antibodies against REXO2
and markers of the mitochondrial outer membrane (TOM20), intermembrane space (AIF), matrix (GDH), inner membrane (NDUFA9). B. Lysates were
prepared from whole HEK293T cells or mitochondria (increasing protein as indicated). OligoRNase activity was then assayed using 100 fmol of RNA5
substrate as detailed in Materials and Methods. C. Mitochondrial lysates were prepared from uninduced HEK293 cells or those expressing REXO2 and
activity assayed as in B. Maximal activity was defined as when all RNA5 was reduced to the shortest product as shown in far right lane. D. Each of the
submitochondrial fractions (1 mg) isolated in panel A were then tested for activity (lanes 2–6). Untreated substrate (RNA5) is shown in lane 1. E.
REXO2 Is a Human Mitochondrial Oligoribonuclease
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Is the enzyme present as a complex ? E. coli ORN has been described
as a dimer based on its chromatographic profile [6]. When
recombinant cytosolic REXO2 was analysed by the same
approach, it eluted as a single predicted mass of ,90 kDa [23].
The authors suggested that this represented either a slowly
migrating rod shaped structure, or a tetrameric complex [23]. In
contrast to this chromatographic approach, we chose to identify
the conformation of the mitochondrial form via Blue Native
PAGE using mitochondrial lysate and on bacterially expressed
purified recombinant mature REXO2. The mitochondrial lysate
gave rise to a single 90–100 kDa complex (Figure 3) consistent
with REXO2 being present as a homotetramer with four mature
monomers of 24.4 kDa. Our untagged recombinant REXO2 also
migrated as a homotetramer with some evidence of larger
multimeric complexes, possibly the consequence of high concen-
trations of purified sample. More importantly, our data demon-
strate the native mitochondrial enzyme appears to present in a
homotetrameric complex.
Loss of REXO2 Affects Cell Growth and Morphology
ORN is required for cell viability in E. coli [7]. Since human
REXO2 is almost 50% identical to its bacterial counterpart [5] we
assessed whether REXO2 is also essential for human cells. Five
different siRNAs independently and specifically caused depletion
of REXO2 protein in several human cell lines (Figures 1, 2, 4 and
data not shown). Those giving over 95% depletion compared to
control cells treated with a non-targetting (NT) siRNA were used
in all experiments reported in this manuscript. Growth rate was
reduced over the first 3 days of REXO2 depletion in HeLa cells
after which cells failed to proliferate and displayed a distinctive
stellate morphology compared to control cells (Figures 4B and C).
To clarify this observation we analysed cell cycle status of control
and depleted cells (Figure 4D). Curiously almost the entire
population of REXO2-depleted cells was stalled in G0/G1 phase
compared to control cells distributed across all phases, suggesting
that cells lacking REXO2 become quiescent rather than die, after
6 days depletion.
Rho0 cells lack mitochondrial DNA, consequently are devoid of
mt-RNA and therefore may be expected to be unaffected if
proteins involved in mitochondrial gene expression are depleted.
In contrast if proteins are crucial for other cell processes, then rho0
cells should be severely affected upon their depletion. Since
REXO2 is present in both the cytosol and mitochondria we aimed
to dissect the importance of REXO2 in each compartment by
depleting human osteosarcoma rho0 cells of REXO2. Interesting-
ly, although REXO2 is present in 143B Rho0 cells, siRNA
mediated depletion of the protein had no significant effect on cell
growth (Figure S3) in contrast to parental 143B Rho+ cells, HeLa
and HEK293 cells all of which showed markedly decreased cell
division. This data strongly suggests that REXO2 plays an
important role in mitochondrial gene expression, which in turn
exerts a level of control of cell division in wild type cells.
REXO2 is Important in Maintaining Mitochondrial
Structure and Function
Since the data from REXO2 depleted rho0 cells indicates an
important role in mitochondrial function, we analysed various
mitochondrial parameters following REXO2 depletion. Changes
to mitochondrial morphology were analysed in HeLa cells with the
lipophilic cationic dye TMRM+. It has been established that the
form of the mitochondrial network varies with the different stages
of the cell cycle with the reticulum being more characteristic of G1
and fragmentation of S phase [28,29]. It was interesting to note
therefore that in contrast to the normal reticulum of actively
growing control cells, cells depleted of REXO2 and confirmed as
G1/G0 arrested led to the punctate and granular mitochondria
associated with S phase, and with mitochondrial dysfunction
[30,31] (Figure 5A).
Single cell measurements were made in cells loaded with
TMRM+ in quench mode (25nM; a condition in which
mitochondrial depolarization increases fluorescence), and sequen-
tially incubated with three respiratory chain inhibitors (oligomycin,
rotenone and antimycin) and then uncoupler FCCP (Figure 5B).
Both control and REXO2 depleted cells (3 days) showed a modest
hyperpolarization to oligomycin, demonstrating that their mito-
chondria are still net ATP generators (oligomycin null test).
However, while control cells showed characteristic double
depolarization after the addition of rotenone and antimycin,
respectively, REXO2 depleted cells with a stellate morphology
were insensitive to rotenone, suggesting a reduced contribution of
complex I to mitochondrial membrane potential when compared
with control cells. Potential is not being held by ATP synthase
reversal (no oligomycin depolarization), thus suggesting a modest
rather than severe respiratory chain impairment after 3 days of
REXO2 depletion. The status of the mitochondrial membrane
potential consistently correlated with the stellate morphology and
indicated that loss of REXO2 impairs respiratory chain function.
Both control and depleted cells were also stained using
PicoGreen to visualise the non-supercoiled DNA in the nucleus
and mitochondrial nucleoids. Interestingly, cells lacking REXO2
appeared to have fewer but larger nucleoids compared to control
cells (Figure 5C).
Mitochondria were extracted from HEK293T cells treated with non-targetting (NT) siRNA (lanes 2, 4) or REXO2 targeted siRNA (lanes 3, 5) and
oligoRNase activity assessed in the indicated amounts of lysate.
doi:10.1371/journal.pone.0064670.g002
Figure 3. Native mitochondrial REXO2 is present as a tetramer.
Purified recombinant REXO2 (2 mg, lane 2) representing the matured
mitochondrial form, together with mitochondrial lysate (100 mg, lane 1)
from HeLa cells were separated through a 5%-18% gradient blue native
polyacrylamide gel. Post-transfer the western blot was interrogated
with antibodies against REXO2. Multimeric forms of recombinant REXO2
are indicated by * and the positions of molecular weight markers are
given. The dashed line is used to indicate that lanes 1 and 2 required 2
different exposure times.
doi:10.1371/journal.pone.0064670.g003
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REXO2 Depletion Severely Affects Mitochondrial Nucleic
Acid Content
To evaluate whether the PicoGreen staining represented
mtDNA depletion or an alteration in mtDNA distribution or
conformation, we used two approaches. First, quantitative PCR
was used to amplify mtDNA corresponding to MTND1 and
MTND4 genes relative to the nuclear 18S rRNA gene. For both
MTND1 and MTND4 REXO2 depletion caused a respective
decrease of 50% (67%) and 65% (610%) after 3 days and 79%
(616%) and 86% (67%) after 6 days. The lack of a significant
difference between levels of the two amplicons, suggests that
REXO2 depletion did not cause deletions but only depletion of
mtDNA. Southern blotting confirmed the depletion of mtDNA
and unexpectedly revealed the apparent disappearance of
mitochondrial 7S DNA in REXO2 depleted cells (Figure 6A).
Northern blots were used to assess whether the observed
mtDNA decrease affected the steady state levels of mitochondrial
RNAs. After 3 days REXO2 depletion mt-mRNAs were most
affected of the 3 transcript types, with only a modest decrease in
16S rRNA (RNR2) and little variation in 12S rRNA (RNR1) or mt-
tRNA levels (Figure 6C, D and E) using 28S signal to correct for
loading. Six days treatment led to a reduction in levels of all
mitochondrial RNA species with mt-mRNAs being the most
affected (Figure 6C, D and E). This data is consistent with global
mitochondrial transcription being affected, as the stability of mt-
rRNAs and mt-tRNAs are far greater than mt-mRNA [32].
Reduction of Mitochondrial RNAs Perturbs de Novo
Synthesis and Steady State Level of Mitochondrial
Polypeptides in REXO2 Depleted Cells
Both mitochondrial DNA and RNA levels appear to decrease as
a consequence of REXO2 depletion. We evaluated the conse-
quences of this on intra-organellar protein synthesis.
De novo synthesis of mtDNA encoded products was assessed by
whole cell metabolic labelling. Mitochondrial protein synthesis was
partially affected after three days of REXO2 depletion and
severely affected after six days treatment (Figure 7A), when
aberrantly migrating polypeptides could also be observed. This
pattern was consistent with the observed reduction of mitochon-
drial RNAs that are required for mitochondrial translation. We
then measured the steady-state levels of COX2 (Complex IV) and
NDUFB8 (Complex I). There was little evidence of change after
3 days but by six days of REXO2 siRNA treatment these subunits
showed a robust decrease in steady state levels when corrected for
b-actin levels (Figure 7B).
Discussion
Correct maintenance of mitochondrial RNA level is crucial for
organellar metabolism. The steady state levels are regulated by
balancing transcription against RNA stability and turnover
(reviewed in [33–36]. Degradation not only contributes to
maintaining mt-RNA levels but also eliminates by-products of
both processing and aberrant transcripts [37]. In eubacteria this
process requires the concerted action of exo- and endo-ribonucle-
ases, giving rise to small oligoribonucleotides that have to be
completely degraded. This last step is essential to recycle and make
available monoribonucleotides for transcription.
Figure 4. Loss of REXO2 affects cell growth and morphology. A. HeLa cells were treated with non-targetting (NT) or REXO2 (RX) directed
siRNAs for 3 or 6 days and cell lysates prepared from these and untransfected (U) controls (20 mg). REXO2 depletion was analysed by western blot
using antibodies against REXO2 with porin and b-actin acting as controls. Cell growth (panel B) and morphology (panel C) were monitored over the
same time period. Cell cycle status was analysed by propidium iodide staining and FACS (panel D). For each reading 10,000 events were sampled.
doi:10.1371/journal.pone.0064670.g004
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Given the essential nature of RNA decay, it has been a
challenging endeavour to identify enzymatic activities responsible
for RNA metabolism in mammalian mitochondria, and very few
RNases have been characterized thus far [12,38]. Further, none of
these enzymes has been demonstrated to be specific for short
oligoribonucleotides. In this paper we report that REXO2 is such
a protein. First, we demonstrate that human REXO2 is a
mitochondrial protein as well as being found in the cytosol.
Interestingly, although there is a single major transcript it contains
two in-frame start codons which are highly conserved. Although
we have not shown unequivocally how the dual targeting
originates, data was consistent with translation initiation from
the upstream AUG generating a protein with a cleavable
presequence that is destined for the mitochondrion, whilst use of
the downstream start site generates the cytosolic form of REXO2.
Such a mechanism would be shared by other mitochondrial
proteins with a dual localization [39,40] including two RNases;
RNase Z, responsible for the removal of 39 extensions from tRNA
precursors [41], and RNase H1, which has a putative role during
mtDNA replication [42].
We demonstrate that mitochondrially localized REXO2 pos-
sesses a 39-59 exonuclease activity specific for small RNA oligomers
(Figure 2) that could be generated during mitochondrial replica-
tion or transcription. The machineries responsible for these two
fundamental processes are contained within nucleoids in the
mitochondrial matrix [43] and the size and distribution of these
Figure 5. Loss of REXO2 affected mitochondrial morphology and mtDNA distribution. A. Representative images of HeLa cells treated with
non-targetting (NT) or REXO2 directed siRNAs for 3 and 6 days. Stellate morphology in REXO2 depleted cells was associated with punctate, yet
polarized (TMRM+ loaded) mitochondria. B. Representative time-lapse recordings of TMRM+ fluorescence (A.F.U, arbitrary fluorescence units) at single
cell resolution, indicative of changes in mitochondrial membrane potential upon sequential complex inhibition with oligomycin (O, 2 mg/ml),
rotenone (R, 1 mM), antimycin (A, 2.5 mM), and uncoupler (F, 1 mM FCCP). Cells with stellate REXO2 morphology were associated with undetectable
rotenone depolarization. C. Representative images of REXO2 depleted cells showing few and abnormally enlarged mitochondrial nucleoids labelled
with PicoGreen, in comparison with the normal abundant small nucleoids in NT controls. White arrows indicate the larger nucleoids present in REXO2
depleted cells.
doi:10.1371/journal.pone.0064670.g005
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features is altered upon REXO2 depletion. We found dual
submitochondrial localization of REXO2. It was detectable in
both the mitochondrial matrix and the IMS. This unusual dual
localization is reminiscent of another mitochondrial RNase,
PNPase. The latter has been localized to the mitochondrial matrix
[44] and the IMS [45] mediating translocation of several RNAs
into mitochondria [46]. PNPase has also been co-purified with the
matrix helicase SUV3; an enzyme with roles in mt-RNA
turnover/surveillance [37] and mtDNA maintenance [47]. More-
over, PNPase and SUV3 are able in vitro to form an active
heteropentameric complex that efficiently degrades structured
RNAs [48] interestingly leaving oligoRNAs of 4 nucleotides in
length [49], which may be in vivo substrates for REXO2. Our data
demonstrate that loss of REXO2 affects mitochondrial structure
and function, causing a disorganized mitochondrial network with
evident punctate and granular mitochondria. Notably, an identical
alteration in the mitochondrial reticulum structure was found
previously in human cells by depleting SUV3 [47] or PNPase [45].
REXO2 depletion also has a negative effect on both replication
and transcription in mitochondria, causing a robust depletion of
mtDNA and of mtRNAs. This result is consistent with a role for
REXO2 as mitochondrial nucleotide scavenger, since both
mtDNA replication and transcription would benefit from
REXO2-mediated recycling of mono-ribonucleotides.
An intriguing finding was the loss of mitochondrial 7S DNA
concomitant with the formation of fewer but larger nucleoids in
REXO2 depleted cells. A similar correlation has been found by
Holt and colleagues in cells over-expressing the accessory subunit
of mitochondrial DNA polymerase c,POLGb [50]. One explana-
tion might be that through a role in recycling the mono-
ribonucleotides necessary for RNA primer synthesis in the D-
loop, REXO2 depletion could negatively affect the synthesis of 7S
DNA. It has been hypothesised that 7S DNA facilitates the
recruitment of ATAD3p, which can mediate nucleoid formation
and division [51]; this, together with the observation of a strong
depletion of mtDNA, could explain the presence of few but large
nucleoids in cells lacking REXO2.
What is the function of REXO2 in the cytosol ? Our work has
not addressed this question directly. The absence of any notable
growth phenotype on depletion of REXO2 from rho0 cells implies
that it does not have an essential function and is not as crucial to
the cell as the mitochondrial form. However, it is possible that the
cytosolic function is maintained even with the very low level of
Figure 6. Loss of REXO2 affects mtDNA and mtRNA levels. A. HeLa cells were treated with non-targetting (NT) or REXO2 (RX) directed siRNAs
for 6 days and DNA prepared. Samples (5 mg) were BamHI digested and separated through a 0.7% agarose gel. The subsequent Southern blot was
probed to reveal levels of mtDNA, 7S DNA and nuclear encoded 18S. Quantitative PCR analysis is presented (panel B). RNA was extracted and
analysed from HeLa cells treated over 3 and 6 days as for A above. Northern blot analysis was performed (panel C) to investigate changes to mt-
mRNA, mt-rRNA levels using 28S as a loading control, whilst high resolution northerns (2 mg RNA/sample) were used to determine changes to mt-
tRNA levels (panel D). Quantitative analysis of data presented in panels C and D is given in panel E.
doi:10.1371/journal.pone.0064670.g006
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REXO2 present after siRNA depletion or there is another enzyme
capable of performing this function.
In conclusion, our data provided the first evidence for an
oligoribonuclease activity in human mitochondria. Our study
demonstrates that REXO2, shares similarities with its bacterial
counterpart, ORN, is important for cell viability, and plays a role
in mtDNA and mtRNA maintenance. Future work will clarify its
function in the IMS and establish interactions with other
mitochondrial RNases.
Supporting Information
Figure S1 REXO2 has conserved two AUG translation
initiation sites. Alignment of five eutherian mammalian
sequences for REXO2 using ClustalW2 shows extremely high
levels of conservation. This is especially evident in the regions of
the two in frame AUG start codons (boxes I and II) and the Kozak
consensus at the downstream AUG (box II). The predicted starting
position of the matured mitochondrial sequence is indicated.
(TIF)
Figure S2 Recombinant REXO2 preparation and oli-
goRNase activity. A. Purified recombinant REXO2 was
separated by 12% PAGE and the gel stained with Coomassie
blue to confirm purity and concentration (Lanes 1–5; 100 ng,
500 ng, 1 mg, 2.5 mg, 5 mg). B. OligoRNase activity was then
assayed using 100 fmol of substrate (lane 1) with increasing
amounts of protein at 37uC (lanes 2–4) and 50uC (lanes 5–7).
(TIF)
Figure S3 REXO2 depletion has no effect on growth of
rho0 cells. 143B rho0 cells were treated with non-targetting (NT)
or REXO2 (RX) siRNA for 3 days. Initial number of cells seeded
is indicated by the dotted line on the graph (A) and the increase in
cell number was analysed, as was cell morphology (B). A western
blot of 143B rho0 cells treated with non-targetting (NT) or
REXO2 (RX) siRNA for 3 days is presented in Panel C. Cell
lysates (40 mg) were separated by 12% SDS PAGE and the blot
interrogated with antibodies to endogenous REXO2 and b actin
as a loading control.
(TIF)
Acknowledgments
The authors would like to thank Joanna Rorbach and Paul Smith for help
in generating preliminary data and Ian Dimmick for assistance with the cell
cycle analyses.
Author Contributions
Conceived and designed the experiments: ZCL RNL. Performed the
experiments: FB PG JO. Analyzed the data: ZCL RNL JO. Wrote the
paper: FB ZCL RNL.
References
1. Arraiano C, Andrade JM, Domingues S, Guinote IB, Malecki M, et al., (2010)
The critical role of RNA processing and degradation in the control of gene
expression. FEMS microbiology reviews,. 34(5): 883–923.
2. Zuo Y, Deutscher MP (2001) Exoribonuclease superfamilies: structural analysis
and phylogenetic distribution. Nucleic acids research 29(5): 1017–1026.
3. Steitz TA, Steitz JA (1993) A general two-metal-ion mechanism for catalytic
RNA. Proc Natl Acad Sci U S A 90(14): 6498–6502.
4. Bernad A, Blanco L, Lazaro JM, Martin G, Salas M (1989) A conserved 39-59
exonuclease active site in prokaryotic and eukaryotic DNA polymerases. Cell
59(1): 219–228.
5. Koonin EV (1997) A conserved ancient domain joins the growing superfamily of
39-59 exonucleases. Current biology : CB,. 7(10): R604–606.
6. Zhang X, Zhu L, Deutscher MP (1998) Oligoribonuclease is encoded by a highly
conserved gene in the 39-59 exonuclease superfamily. Journal of bacteriology,.
180(10): 2779–2781.
Figure 7. Loss of REXO2 perturbs de novo synthesis and steady state levels of mitochondrially encoded proteins. HeLa cells were
treated with non-targetting (NT) or REXO2 siRNA for 3 and 6 days after which cytosolic translation was inhibited and mitochondrial protein synthesis
analysed by 35S met/cys incorporation (2 hr followed by a 1 hr chase). Cell lysate (50 mg) was separated through 15–20% PAG. Post fixation and
drying the signal was visualised by STORM 860 PhosphorImaging and ImageQuant software (GE Healthcare Life Sciences). The gel was rehydrated
and stained with Coomassie blue (CBB) to confirm equal loading. Signals were ascribed following migration patterns described in [24] and aberrant
products in lane 4 are indicated by asterisks. B. Steady state levels of mitochondrial proteins from cells treated as in (A) were analysed by western
blot of cell lysates (25 mg). Antibodies were used against REXO2, a mtDNA-encoded protein (COXII), a nuclear encoded complex I protein (NDUFB8), a
nuclear encoded mitochondrial protein (porin) and a cytosolic control (b-actin).
doi:10.1371/journal.pone.0064670.g007
REXO2 Is a Human Mitochondrial Oligoribonuclease
PLOS ONE | www.plosone.org 10 May 2013 | Volume 8 | Issue 5 | e64670
7. Ghosh S. Deutscher MP (1999) Oligoribonuclease is an essential component of
the mRNA decay pathway. Proc Natl Acad Sci U S A 96(8): 4372–4377.
8. Goldman SR, Sharp JS, Vvedenskaya IO, Livny J, Dove SL, et al. (2011)
NanoRNAs prime transcription initiation in vivo. Molecular cell 42(6): 817–825.
9. Hanekamp T, Thorsness PE (1999) YNT20, a bypass suppressor of yme1 yme2,
encodes a putative 39-59 exonuclease localized in mitochondria of Saccharomy-
ces cerevisiae. Current genetics 34(6): 438–448.
10. Leonhard K, Herrmann JM, Stuart RA, Mannhaupt G, Neupert W, et al. (1996)
AAA proteases with catalytic sites on opposite membrane surfaces comprise a
proteolytic system for the ATP-dependent degradation of inner membrane
proteins in mitochondria. EMBO Journal 15(16): 4218–4229.
11. van Hoof A, Lennertz P, Parker R (2000) Three conserved members of the
RNase D family have unique and overlapping functions in the processing of 5S,
5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. The EMBO journal
19(6): 1357–1365.
12. Rorbach J, Minczuk M (2012) The post-transcriptional life of mammalian
mitochondrial RNA. The Biochemical Journal 444(3): 357–373.
13. King MP, Attardi G (1989) Human Cells Lacking mtDNA: Repopulation with
Exogenous Mitochondria by Complementation. Science 246: 500–503.
14. Soleimanpour-Lichaei HR, Kuhl I, Gaisne M, Passos JF, Wydro M, et al. (2007)
mtRF1a is a human mitochondrial translation release factor decoding the major
termination codons UAA and UAG. Molecular Cell 27(5): 745–757.
15. Ovcharenko D, Jarvis R, Hunicke-Smith S, Kelnar K, Brown D (2005) High-
throughput RNAi screening in vitro: from cell lines to primary cells. RNA 11(6):
985–993.
16. Rorbach J, Richter R., Wessels HJ, Wydro M, Pekalski M, et al. (2008) The
human mitochondrial ribosome recycling factor is essential for cell viability.
Nucleic Acids Research 36(18): 5787–5799.
17. Oliveira JM (2011)Techniques to investigate neuronal mitochondrial function
and its pharmacological modulation. Current Drug Targets 12(6): 762–773.
18. Chrzanowska-Lightowlers ZM, Preiss T, Lightowlers RN (1994) Inhibition of
mitochondrial protein synthesis promotes increased stability of nuclear-encoded
respiratory gene transcripts. The Journal of Biological Chemistry 269(44):
27322–27328.
19. Rorbach J, Yusoff AA, Tuppen H, Abg-Kamaludin DP, Chrzanowska-
Lightowlers ZM, et al. (2008) Overexpression of human mitochondrial valyl
tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying
the pathogenic C25U mutation. Nucleic Acids Research 36(9): 3065–3074.
20. Anderson S, Bankier AT, Barrell BG, De Bruijn MHL, Coulson AR, et al.
(1981) Sequence and organization of the human mitochondrial genome. Nature
290(5806): 457–465.
21. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al.
(1999) Reanalysis and revision of the Cambridge reference sequence for human
mitochondrial DNA. Nature Genetics 23(2): 147.
22. Nijtmans LGJ, Henderson N, Holt IJ (2002) Blue Native electrophoresis to study
mitochondrial and other protein complexes. Methods 26: 327–334.
23. Nguyen LH, Erzberger JP, Root J, Wilson DM (2000)The human homolog of
Escherichia coli Orn degrades small single-stranded RNA and DNA oligomers.
The Journal of Biological Chemistry 275(34): 25900–25906.
24. Chomyn A (1996) In vivo labeling and analysis of human mitochondrial
translation products. Methods Enzymol. 264: 197–211.
25. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, et al. (2008) A
mitochondrial protein compendium elucidates complex I disease biology. Cell
134(1): 112–123.
26. Kozak M (1989) Context effects and inefficient initiation at non-AUG codons in
eucaryotic cell-free translation systems. Molecular and Cellular Biology 9(11):
5073–5080.
27. Niyogi SK, Datta AK (1975) A novel oligoribonuclease of Escherichia coli. I.
Isolation and properties. The Journal of Biological Chemistry 250(18): 7307–
7312.
28. Barni S, Sciola L, Spano A, Pippia P (1996) Static cytofluorometry and
fluorescence morphology of mitochondria and DNA in proliferating fibroblasts.
Biotechnic & histochemistry : official publication of the Biological Stain
Commission 71(2): 66–70.
29. Margineantu DH, Gregory Cox W, Sundell L, Sherwood SW, Beechem JM, et
al. (2002) Cell cycle dependent morphology changes and associated mitochon-
drial DNA redistribution in mitochondria of human cell lines. Mitochondrion
1(5): 425–435.
30. Chen H, Chan DC (2009) Mitochondrial dynamics–fusion, fission, movement,
and mitophagy in neurodegenerative diseases. Human Molecular Genetics
18(R2): R169–176.
31. Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, et al. (2009) Complex II
inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death
via an NMDA- and ROS-dependent pathway. Cell Death and Differentiation
16(6): 899–909.
32. Chrzanowska-Lightowlers ZMA, Preiss T, Lightowlers RN (1994) Inhibition of
Mitochondrial Protein Synthesis Promotes Increased Stability of Nuclear-
encoded Respiratory Gene Transcripts. The Journal of Biological Chemistry
269(44): 27322–27328.
33. Borowski LS, Szczesny RJ, Brzezniak LK, Stepien PP (2010) RNA turnover in
human mitochondria: more questions than answers? Biochimica et Biophysica
Acta 1797(6–7): 1066–1070.
34. Gagliardi D, Stepien PP, Temperley RJ, Lightowlers RN, Chrzanowska-
Lightowlers ZM (2004) Messenger RNA stability in mitochondria: different
means to an end. Trends in Genetics 20(6): 260–267.
35. Temperley RJ, Wydro M, Lightowlers RN, Chrzanowska-Lightowlers ZM
(2010) Human mitochondrial mRNAs: like members of all families, similar but
different. Biochimica et Biophysica Acta 1797(6–7): 1081–1085.
36. Szczesny RJ, Borowski LS, Malecki M, Wojcik MA, Stepien PP, et al. (2012)
RNA degradation in yeast and human mitochondria. Biochimica et Biophysica
Acta 1819(9–10): 1027–1034.
37. Szczesny RJ, Borowski LS, Brzezniak LK, Dmochowska A, Gewartowski K, et
al. (2010) Human mitochondrial RNA turnover caught in flagranti: involvement
of hSuv3p helicase in RNA surveillance. Nucleic Acids Research 38(1): 279–298.
38. Bruni F, Gramegna P, Lightowlers RN, Chrzanowska-Lightowlers ZM (2012)
The mystery of mitochondrial RNases. Biochemical Society Transactions 40(4):
865–869.
39. Karniely S, Pines O (2005) Single translation–dual destination: mechanisms of
dual protein targeting in eukaryotes. EMBO reports 6(5): p.420–425.
40. Yogev O, Pines O (2011) Dual targeting of mitochondrial proteins: mechanism,
regulation and function. Biochimica et Biophysica Acta 1808(3): 1012–1020.
41. Rossmanith W (2011) Localization of human RNase Z isoforms: dual nuclear/
mitochondrial targeting of the ELAC2 gene product by alternative translation
initiation. PloS One 6(4): e19152.
42. Suzuki Y, Holmes JB, Cerritelli SM, Sakhuja K, Minczuk M, et al. (2010) An
upstream open reading frame and the context of the two AUG codons affect the
abundance of mitochondrial and nuclear RNase H1. Molecular and Cellular
Biology 30(21): 5123–5134.
43. Spelbrink JN (2010) Functional organization of mammalian mitochondrial DNA
in nucleoids: history, recent developments, and future challenges. IUBMB life
62(1): 19–32.
44. Borowski LS, Dziembowski A, Hejnowicz MS, Stepien PP, Szczesny RJ (2013)
Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes
place in distinct foci. Nucleic Acids Research 41(2): 1223–1240.
45. Chen HW, Rainey RN, Balatoni CE, Dawson DW, Troke JJ, et al. (2006)
Mammalian polynucleotide phosphorylase is an intermembrane space RNase
that maintains mitochondrial homeostasis. Molecular and Cellular Biology
26(22): 8475–8487.
46. Wang G, Chen HW, Oktay Y, Zhang J, Allen EL, et al. (2010) PNPASE
regulates RNA import into mitochondria. Cell 142(3): 456–467.
47. Khidr L, Wu G, Davila A, Procaccio V, Wallace D, et al. (2008) Role of SUV3
helicase in maintaining mitochondrial homeostasis in human cells. The Journal
of Biological Chemistry 283(40): 27064–27073.
48. Wang DD, Shu Z, Lieser SA, Chen PL, Lee WH (2009) Human mitochondrial
SUV3 and polynucleotide phosphorylase form a 330-kDa heteropentamer to
cooperatively degrade double-stranded RNA with a 39-to-59 directionality. The
Journal of Biological Chemistry 284(31): 20812–20821.
49. Lin CL, Wang YT, Yang WZ, Hsiao YY, Yuan HS (2012) Crystal structure of
human polynucleotide phosphorylase: insights into its domain function in RNA
binding and degradation. Nucleic Acids Research 40(9): 4146–4157.
50. Di Re M, Sembongi H, He J, Reyes A, Yasukawa T, et al. (2009) The accessory
subunit of mitochondrial DNA polymerase gamma determines the DNA content
of mitochondrial nucleoids in human cultured cells. Nucleic Acids Research
37(17): 5701–5713.
51. Holt IJ, He J, Mao CC, Boyd-Kirkup JD, Martinsson P, et al. (2007)
Mammalian mitochondrial nucleoids: organizing an independently minded
genome. Mitochondrion 7(5): 311–321.
REXO2 Is a Human Mitochondrial Oligoribonuclease
PLOS ONE | www.plosone.org 11 May 2013 | Volume 8 | Issue 5 | e64670
